Newsletter
Newsletter Support JNS

Former Israeli prime minister Barak appointed chair of medical marijuana company

In a statement, InterCure said Ehud Barak’s “stature” will be helpful for the company’s development.

Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.
Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

Former Israeli Prime Minister Ehud Barak will chair the Israeli medical marijuana company InterCure, according to the firm, which made the announcement on Wednesday.

Barak served as defense minister and then prime minister in the early 2000s. He has remained in the public spotlight since leaving politics, usually criticizing current government policies.

InterCure said that Barak will head its global growth initiative. In a statement, the company said Barak’s “stature” will be helpful for the company’s development.

Barak will work 40 monthly hours for $10,000 per month. He will also be eligible for stock options, according to the company.

InterCure, publicly traded in Israel, is expected to change its name to Canndoc Pharma.

“Of all the things left for Shlock Rock to do, this was one of them,” lead singer Lenny Solomon told JNS. “I had played Birmingham. I had played Montgomery, but I had never played Mobile.”
According to the party, 76,068 members voted, a turnout of 53%.
“There is democracy within Likud,” Israeli Transportation and Road Safety Minister Miri Regev told JNS.
“The Saudi curriculum has never been more positive in its portrayal of religious minorities or more encouraging of peace and tolerance,” said IMPACT-se CEO Marcus Sheff.